<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="17698">Chloramphenicol</z:chebi> (CAP), a board spectrum antibiotic widely used in many developing countries, has toxic side effects on bone marrow, the most serious of which is <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies suggest that effects of CAP on suppressing hematopoietic colony formation may be abrogated by <z:chebi fb="11" ids="22586">antioxidants</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, there is preliminary evidence that CAP induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in hemopoietic stem cells, leading to <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We have been unable to demonstrate the protective effects of a variety of <z:chebi fb="11" ids="22586">antioxidants</z:chebi> on CAP-induced suppression of burst-forming unit erythroid (BFU-E) and colony-forming unit granulocyte/monocyte (CFU-GM) </plain></SENT>
<SENT sid="4" pm="."><plain>Using flow cytometry, we have, however, confirmed that CAP can induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in purified human bone marrow CD34+ cells </plain></SENT>
<SENT sid="5" pm="."><plain>We also showed that a caspase inhibitor, Z-VAD.fmk, can ameliorate the apoptotic-inducing effects of CAP in the <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 cell line </plain></SENT>
</text></document>